Analysts' Actions: EBAY HAL LMCA MET TWTR

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Abbott
( ABT) was upgraded at Morgan Stanley to overweight. Twelve-month price target is $45. Company is cutting costs and earnings growth can reaccelerate, Morgan Stanley said.

Ameren
( AEE) was upgraded at Wells Fargo to outperform from market perform. Company has a healthy dividend yield and can deliver above-average earnings growth, Wells Fargo said.

Alexion ( ALXN) was downgraded at Goldman Sachs to neutral from buy. Valuation call, based on a 12-month price target of $140, Goldman said.

CR Bard (BCR) was downgraded at J.P. Morgan to neutral from overweight. Valuation call, as the stock gained 37% in 2013, J.P. Morgan said.

Boston Scientific (BSX) was upgraded at Morgan Stanley to overweight from equal-weight. $15 price target. Growth story will likely emerge in 2014, Morgan Stanley said.

BancorpSouth (BXS) was downgraded at Morgan Stanley to underweight from equal-weight. Valuation call, as the stock gained 75% in 2013, Morgan Stanley said.

Celgene (CELG) was downgraded at Goldman Sachs to sell from neutral. Valuation call, based on a 12-month price target of $140, Goldman said.

Con-Way (CNW) was downgraded at Bank of America/Merrill Lynch to underperform from buy. Twelve-month price target is $36. Turnaround is slower than expected, BofA/Merrill said.

eBay ( EBAY) was downgraded at Morgan Stanley to equal-weight. There are risks to earnings, and the company lacks near-term catalysts, Morgan Stanley said. Twelve-month price target is $57.

Engility Holdings ( EGL) was upgraded to hold at TheStreet Ratings.

Entergy ( ETR) was downgraded at Wells Fargo to market perform from outperform. Indian Point is clouding the growth outlook, Wells Fargo said.

First Solar ( FSLR) was downgraded at Goldman Sachs to sell from buy. Twelve-month price target is $45. Company will likely grow slower than its peers in the near term, Goldman said.


Genworth Financial ( GNW) was upgraded at UBS to buy from neutral. Above-peer ROE improvement will drive better P/B expansion, UBS said. Twelve-month price target is $18. EPS estimates were increased.

Halliburton ( HAL) was upgraded at Wells Fargo to outperform from market perform. Valuation call, as the stock has pulled back 7%, Wells Fargo said.

HollyFrontier (HFC) was downgraded at Citigroup to sell from neutral. Twelve-month price target is $40. Valuation call, Citigroup said.

Honda Motor (HMC) was upgraded to buy at TheStreet Ratings.

Hologic (HOLX) was downgraded at Morgan Stanley to equal-weight from overweight. Stock appears fully valued at current levels, Morgan Stanley said.

Liberty Media (LMCA) was upgraded at Wunderlich to buy from hold. Sirius XM (SIRI) deal should enable the company to remain an active dealmaker, Wunderlich said.

Medtronic (MDT) was upgraded at J.P. Morgan to overweight from neutral. Company is entering an important new product cycle, J.P. Morgan said.

MetLife (MET) was downgraded at UBS to neutral from buy. Driven by a slower shift of business mix and ongoing uncertainty around regulation that will delay MET's ability to resume capital management, UBS said.

MGM Resorts International (MGM) was upgraded at Citigroup to buy from neutral. Twelve-month price target is $28. Positive balance sheet changes and encouraging ADR trends, Citigroup said.

MineSafety (MSA) was upgraded at Robert Baird to outperform from neutral. Company should benefit from a gradual improvement in global industrial activity, Robert Baird said.

RetailMeNot (SALE) was upgraded at RBC Capital to outperform from sector perform. Twelve-month price target is $33. Mobile and local Internet focus should drive growth, RBC Capital said.


SolarCity (SCTY) was upgraded at Goldman Sachs to buy from neutral. Company was also placed on the Conviction List, Goldman said. Twelve-month price target is $80. Company should benefit from fast rooftop growth, Goldman said.

St. Jude (STJ) was upgraded at Morgan Stanley to overweight from equal-weight. $75 price target. Organic growth is accelerating, Morgan Stanley said.

Trulia (TRLA) was upgraded at RBC Capital to outperform from sector perform. $54 price target. Stock has pulled back and the company has strong growth potential, RBC Capital said.

Twitter (TWTR) was downgraded at Morgan Stanley to underweight from equal-weight. Valuation call, based on a 12-month price target of $33, Morgan Stanley said.

Vertex Pharm (VRTX) was upgraded at UBS to buy from neutral. Driven by confidence that lumicaftor-ivacaftor combination will be successful in 2014 Phase 3 readouts in cystic fibrosis, UBS said. Twelve-month price target is $99.

Zillow (Z) was upgraded at RBC Capital to outperform from sector perform. Twelve-month price target is $100. Company can execute within a secular growth industry, RBC Capital said.

Stock Comments / EPS Changes

Biogen Idec
(BIIB) numbers were raised at Goldman Sachs. Shares are now seen reaching $283 over 12 months. Estimates were also increased, given the company's solid pipeline, Goldman said. Neutral rating.

Buffalo Wild Wings (BWLD) price target, EPS estimates were increased at Jefferies. Driven by more favorable chicken wing prices, Jefferies said. Hold rating and 12-month price target of $148.

Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.

If you liked this article you might like

Walmart's Slowing E-Commerce Growth Shows Just How Formidable Amazon Is

Walmart's Slowing E-Commerce Growth Shows Just How Formidable Amazon Is

TheStreet Podcast: Go Inside the Goldman Sachs Tech & Internet Conference

TheStreet Podcast: Go Inside the Goldman Sachs Tech & Internet Conference

PayPal COO Talks to TheStreet About eBay Deal, Growth Plans and Blockchain

PayPal COO Talks to TheStreet About eBay Deal, Growth Plans and Blockchain

Make PayPal Your Friend With This Trade

Make PayPal Your Friend With This Trade

PayPal Finance Chief: Wall Street Need Not Worry About Our eBay Relationship

PayPal Finance Chief: Wall Street Need Not Worry About Our eBay Relationship